Navigation Links
National Stem Cell Holding, Inc. Posts Company and Financial Information on the OTCIQ and Has Retained New CFO and Counsel to File Registration Statement With SEC
Date:12/17/2007

MOUNTAINSIDE, N.J., Dec. 17 /PRNewswire-FirstCall/ -- National Stem Cell Holding, Inc. (Other OTC: NHGI) today announced that its company information, financial information, quotations and press releases are posted on the OTCIQ, a service of the Pink Sheets.

OTCIQ is a secure, web-based portal that provides issuers access to innovative products and services to facilitate communication with the marketplace, promote transparency, mitigate risk, gather market intelligence, and inspire better corporate governance. OTCIQ subscribers are assigned secure, personalized user credentials to manage the publication and dissemination of all of their corporate information and public disclosures.

The OTCIQ service includes:

secure user login

Pink Sheets News Service -

Publication of:

Disclosure Statements

Financial Reports

News Releases

Real-time Level II quotes

Michael Cohen, President, stated: "We have taken the early steps in good faith to report our up-to-date information on the OTCIQ. I am also pleased to announce that we have retained a CFO and a new general counsel that has propelled the company in a short period of time closer to filing SEC documentation to become a fully reporting company."

National Stem Cell Holding, Inc. is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. The Company is developing a pipeline of proprietary stem cell therapeutics with particular focus on diabetes. In addition to its work with stem cell therapeutics, the Company is also working to leverage its commercial infrastructure and product development capabilities of its wholly-owned subsidiary The Sperm Bank of NY. The Company's investigational products are focused on the improvement of the quality of life for patients and their families. The Company is headquartered in Mountainside, NJ. For more information, please visit http://www.nationalstemcell.com and http://www.pinksheets.com .

"Safe Harbor Statement" Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The results anticipated by any or all of these forward-looking statements may not occur. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect

events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.


'/>"/>
SOURCE National Stem Cell Holding, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Brazilian National Biosafety Technical Committee Approves Monsanto Company Insect-Protected Corn Trait
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
4. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
5. The Government of Quebec and the New Canadian Government Invest in the Creation of an International Biobank
6. International Isotopes Inc. Announces Completion of an Exclusive Distributor Agreement for Sales of New Style Transportation Containers
7. Arrow International Files and Mails Definitive Proxy Materials
8. Niceware International Announces Licensed Vendor Status with ICCBBA, Inc. to Provide ISBT 128-compliant Software
9. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
10. Viragen International to Reverse Split Its Common Stock
11. Tutogen Medical, Inc. and Zimmer Holdings, Inc. Announce Agreement for International Distribution of Biological Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... ... 16, 2017 , ... Appellate Court of New Jersey approved ... filed by India-based Dishman Pharmaceutical & Chemical Ltd. company (DPCL) for its motion ... its Dishman Group’s 100% wholly owned New Jersey-based subsidiary Dishman USA located in ...
(Date:1/16/2017)... , Jan. 16, 2017  Eurofins Genomics today announced ... allow more customers to receive their primers in a ... compromise in quality found with other providers. Express oligos ... States at no additional fee. ... genetic studies, including DNA sequencing, genotyping, site-directed mutagenesis, and ...
(Date:1/13/2017)... 13, 2017 Research and Markets has announced ... - Global Forecast to 2021" report to their offering. ... The biosimilars market ... 3.39 Billion in 2016, at a CAGR of 26.3%. ... product, manufacturing type, and application. Factors such as rising incidence of ...
(Date:1/13/2017)... (PRWEB) , ... January 13, 2017 , ... ... every cuvette-related demand that it has found among its diverse customer base. The ... for use in most brands electroporators including BTX and Bio-Rad. FireflySci is introducing ...
Breaking Biology Technology:
(Date:12/7/2016)... PUNE, India , December 7, 2016 According to ... NLP, Machine Learning), Software Tool (Facial Expression, Voice Recognition), Service, Application Area, End ... size is estimated to grow from USD 6.72 Billion in 2016 to USD ... Continue Reading ... ...
(Date:12/7/2016)... LONDON , Dec. 7, 2016   Avanade ... most successful Formula One teams in history, exploit biometric ... pit stop performance and maintain the competitive edge against ... in 2016. Avanade has worked with ... a range of biometric data (heart rate, breathing rate, ...
(Date:12/6/2016)... , Dec. 6, 2016  Zimmer Biomet Holdings, Inc. ... has priced an offering of €500.0 million principal amount of ... principal amount of its 2.425% senior unsecured notes due 2026. ... to occur on December 13, 2016, subject to the satisfaction of ... annual basis. The Company intends ...
Breaking Biology News(10 mins):